Antiosteoporotic pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient
First Claim
Patent Images
1. A method for the treatment of osteoporosis, which comprises administering to a patient suffering from osteoporosis an effective amount of a compound of 24,25-dihydroxycholecalciferol.
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed herein is a pharmaceutical composition in dosage unit form, which comprises a dosage effective for treating osteoporosis of a compound of 24,25-dihydroxycholecalciferol and a pharmaceutically acceptable carrier.
12 Citations
2 Claims
- 1. A method for the treatment of osteoporosis, which comprises administering to a patient suffering from osteoporosis an effective amount of a compound of 24,25-dihydroxycholecalciferol.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeKureha Kagaku Kogyo Kabushiki Kaisha
-
Original AssigneeKureha Kagaku Kogyo Kabushiki Kaisha
-
InventorsSaito, Kenichi, Fujii, Takayoshi, Yamato, Hideyuki, Maeda, Yuji, Kobayashi, Yasuhiko, Yoshikumi, Chikao, Kato, Tadaaki
-
Primary Examiner(s)Roberts, Elbert L.
-
Application NumberUS06/662,044Time in Patent Office579 DaysField of Search424/236, 260/397.2, 514/167US Class Current514/167CPC Class CodesA61K 31/59 Compounds containing 9, 10-...A61P 3/00 Drugs for disorders of the ...A61P 43/00 Drugs for specific purposes...
